The Birlinn BCR-ABL1 p210 IS Panel C230 is intended to monitor the detection and quantification of BCR-ABL1 (p210) fusion gene using molecular test systems, and allows calculation of a Conversion Factor (CF) necessary to express quantification results (M-bcr transcript of BCR-ABL1 p210 relative to the ABL1 transcript) according to the International Scale (IS). Each component of the panel contains an increasing concentration of BCR-ABL1 RNA transcript mixed with a fixed concentration of ABL1 RNA transcript to produce five levels, 0.0032%, 0.01%, 0.1%, 1% and 10%. The %IS values provided are traceable to World Health Organization Reference Panel, NIBSC code 09/138, and are assigned to each lot of the Birlinn BCR-ABL1 p210 IS Panel C230 according to NIBSC Instructions for Use. This control has been tested and is compatible with assays on multiple platforms, including AB Analitica, QIAGEN, Bioclarma, and BIO-RAD. Reach out to MMQCI to ask about compatibility with your specific assay.